Literature DB >> 12798528

Alcohol consumption and the risk of borderline and invasive ovarian cancer.

Marc T Goodman1, Ko Hui Tung.   

Abstract

OBJECTIVE: To examine the hypothesis that alcohol consumption is associated with the risk of ovarian cancer by conducting a population-based, case-control study in Hawaii and Los Angeles, California.
METHODS: In-person interviews were obtained from 558 women with ovarian cancer and 607 population controls regarding lifetime alcohol consumption and other factors that may be related to the development of ovarian cancer.
RESULTS: We found no overall association of alcohol drinking with the odds ratios (OR) for ovarian cancer. However, current alcohol drinkers, but not former drinkers, had a significantly lower OR for ovarian cancer compared with never drinkers (OR 0.69, 95% confidence interval [CI] 0.50, 0.96). Odds ratios for ovarian cancer associated with the current consumption of beer, wine, and spirits were also reduced, but were only significant for wine drinkers. Among current wine drinkers, women who drank red wine had a significantly reduced OR for ovarian cancer compared with never drinkers (OR 0.61, 95% CI 0.39, 0.94). The inverse association of current alcohol drinking with the OR for ovarian cancer was restricted to invasive tumors, especially the endometrioid cell type. The number of glasses of alcohol consumed on a weekly basis was inversely related to the OR for invasive ovarian cancer (P =.009): Current drinkers consuming 14 or more drinks per week had an OR of 0.36 (95% CI 0.19, 0.70) compared with never drinkers. A significantly increased risk of borderline serous tumors was associated with the use of spirits (OR 2.66, 95% CI 1.46, 4.85). The risk for borderline mucinous tumors was also significantly elevated for former wine drinkers.
CONCLUSIONS: These findings suggest that the association of alcohol consumption with the OR for ovarian cancer may vary by alcohol type, tumor invasiveness, and histology.

Entities:  

Mesh:

Year:  2003        PMID: 12798528     DOI: 10.1016/s0029-7844(03)00050-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  Wine drinking and epithelial ovarian cancer risk: a meta-analysis.

Authors:  Hee Seung Kim; Jae Weon Kim; Leo J Shouten; Susanna C Larsson; Hyun Hoon Chung; Yong Beom Kim; Woong Ju; Noh Hyun Park; Yong Sang Song; Seung Cheol Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.

Authors:  Holly R Harris; Daniel W Cramer; Allison F Vitonis; Mary DePari; Kathryn L Terry
Journal:  Int J Cancer       Date:  2011-11-08       Impact factor: 7.396

3.  Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Authors:  Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

4.  Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.

Authors:  Tomas Riman; Paul W Dickman; Staffan Nilsson; Hans Nordlinder; Cecilia M Magnusson; Ingemar R Persson
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Flavonoid intake and ovarian cancer risk in a population-based case-control study.

Authors:  Margaret A Gates; Allison F Vitonis; Shelley S Tworoger; Bernard Rosner; Linda Titus-Ernstoff; Susan E Hankinson; Daniel W Cramer
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

6.  Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort.

Authors:  Ellen T Chang; Alison J Canchola; Valerie S Lee; Christina A Clarke; David M Purdie; Peggy Reynolds; Leslie Bernstein; Daniel O Stram; Hoda Anton-Culver; Dennis Deapen; Harvey Mohrenweiser; David Peel; Rich Pinder; Ronald K Ross; Dee W West; William Wright; Argyrios Ziogas; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2007-02       Impact factor: 2.506

7.  Epidemiology of ovarian cancer: a review.

Authors:  Brett M Reid; Jennifer B Permuth; Thomas A Sellers
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

8.  Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.

Authors:  Linda E Kelemen; Elisa V Bandera; Kathryn L Terry; Mary Anne Rossing; Louise A Brinton; Jennifer A Doherty; Roberta B Ness; Susanne Krüger Kjaer; Jenny Chang-Claude; Martin Köbel; Galina Lurie; Pamela J Thompson; Michael E Carney; Kirsten Moysich; Robert Edwards; Clare Bunker; Allan Jensen; Estrid Høgdall; Daniel W Cramer; Allison F Vitonis; Sara H Olson; Melony King; Urmila Chandran; Jolanta Lissowska; Montserrat Garcia-Closas; Hannah Yang; Penelope M Webb; Joellen M Schildkraut; Marc T Goodman; Harvey A Risch
Journal:  BMC Cancer       Date:  2013-01-22       Impact factor: 4.430

9.  Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies.

Authors:  J M Genkinger; D J Hunter; D Spiegelman; K E Anderson; J E Buring; J L Freudenheim; R A Goldbohm; L Harnack; S E Hankinson; S C Larsson; M Leitzmann; M L McCullough; J Marshall; A B Miller; C Rodriguez; T E Rohan; A Schatzkin; L J Schouten; A Wolk; S M Zhang; S A Smith-Warner
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.

Authors:  Tomotaka Ugai; Linda E Kelemen; Mika Mizuno; Jue-Sheng Ong; Penelope M Webb; Georgia Chenevix-Trench; Kristine G Wicklund; Jennifer Anne Doherty; Mary Anne Rossing; Pamela J Thompson; Lynne R Wilkens; Michael E Carney; Marc T Goodman; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Hui Cai; Xiao-Ou Shu; Yu-Tang Gao; Yong-Bing Xiang; David Van Den Berg; Malcom C Pike; Anna H Wu; Celeste Leigh Pearce; Keitaro Matsuo
Journal:  Cancer Sci       Date:  2018-01-21       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.